APA (7th ed.) Citation

SA, B., X, W., D, S., Y, W., RD, C., YH, L., . . . M, R. (2025). Characterization of the tautomeric equilibrium of molnupiravir, an antiviral for the treatment of COVID-19. Journal of pharmaceutical and biomedical analysis, 265, 117025. https://doi.org/10.1016/j.jpba.2025.117025

Chicago Style (17th ed.) Citation

SA, Burgess, Wang X, Stueber D, Wang Y, Cohen RD, Lam YH, Iuzzolino L, and Reibarkh M. "Characterization of the Tautomeric Equilibrium of Molnupiravir, an Antiviral for the Treatment of COVID-19." Journal of Pharmaceutical and Biomedical Analysis 265 (2025): 117025. https://doi.org/10.1016/j.jpba.2025.117025.

MLA (9th ed.) Citation

SA, Burgess, et al. "Characterization of the Tautomeric Equilibrium of Molnupiravir, an Antiviral for the Treatment of COVID-19." Journal of Pharmaceutical and Biomedical Analysis, vol. 265, 2025, p. 117025, https://doi.org/10.1016/j.jpba.2025.117025.